Continuous renal replacement therapy (CRRT) has been used in intensive
care units particularly in patients with sepsis or multiorgan failure
. In comparison to intermittent haemodialysis, hemofiltration techniqu
es offers an improved hemodynamic tolerance, related to the absence of
osmotic pressure gradient. Indeed, hemofiltration is based on the phy
sical principle of convection to remove substances from the plasma. Th
e removal of substances that are released during sepsis, acute respira
tory distress syndrome or multiorgan failure may be of particular inte
rest. Several human studies have demonstrated that hemofiltration remo
ves various inflammatory mediators, but the clinical significance of t
his removal remains questionnable. If this removal occurs predominantl
y by convection, interrest in hemofiltration will focus on high volume
hemofiltration in order to obtain maximal ultrafiltrate flows. Patien
ts with sepsis or multiorgan failure require close monitoring of most
vital fonctions. The use of a CRRT technique emphasizes the importance
of this monitoring and adds new monitoring issues relative to fluid b
alance, anticoagulation, hypothermia or drug removal.